AI & ChatGPT searches , social queriess for LANREOTIDE
Search references for LANREOTIDE. Phrases containing LANREOTIDE
See searches and references containing LANREOTIDE!
Search references for LANREOTIDE. Phrases containing LANREOTIDE
See searches and references containing LANREOTIDE!LANREOTIDE
Pharmaceutical drug
Lanreotide, sold under the brand name Somatuline among others, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine
Lanreotide
Type of endocrine gland cancer
such as octreotide, can reduce the excessive production of hormones. Lanreotide can slow tumor growth. If the tumor is not amenable to surgical removal
Pancreatic_cancer
Tumors of the endocrine and nervous systems
given by injection under the skin or into the muscle. Octreotide and Lanreotide are the two somatostatin analogs currently approved by the Food and Drug
Neuroendocrine_tumor
Tumor of the pituitary gland
to treatment with somatostatin receptor ligands such as octreotide or lanreotide. In people with thyrotropinomas, treatment with somatostatin receptor
Pituitary_adenoma
Human disease that results in excess growth of certain parts of the body
acromegaly is to use somatostatin analogues – octreotide (Sandostatin) or lanreotide (Somatuline). Somatostatin analogues are also sometimes used to shrink
Acromegaly
Human growth disorder
pains Causes Hyperplasia in the pituitary gland Treatment Surgically remove the enlarged pituitary gland Medication Octreotide, lanreotide or pegvisomant
Gigantism
Presence of excess fat in feces
include orlistat, a slimming pill, or as adverse effect of octreotide or lanreotide, used to treat acromegaly or other neuroendocrine tumors. It can be found
Steatorrhea
Peptide used as medication
degradation. Another peptide known to self-assemble is the octapeptide Lanreotide. This compound is a synthetic analogue of the peptide hormone somatostatin
Peptide_therapeutics
American politician (born 1974)
lymph nodes, 20 of which were cancerous. His treatment includes monthly Lanreotide injections to slow the tumors' growth, and he receives cancer scans every
Joaquin_Castro
Peptide hormone that stimulates growth
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Growth_hormone
Octapeptide that mimics natural somatostatin pharmacologically
patients who have responded to and tolerated treatment with octreotide or lanreotide. Mycapssa is the first oral somatostatin analog (SSA) approved by the
Octreotide
Peptide hormone that regulates the endocrine system
finding increased use in polycystic diseases of the liver and kidney. Lanreotide (Somatuline, Ipsen Pharmaceuticals) is a medication used in the management
Somatostatin
Slow-growing type of neuroendocrine tumor
Chemotherapy is of little benefit and is generally not indicated. Octreotide or lanreotide (somatostatin analogues) may decrease the secretory activity of the carcinoid
Carcinoid
French biopharmaceutical company
inhibitor for women at high-risk of breast cancer recurrence. Somatuline (lanreotide) is a synthetic version of the natural hormone somatostatin, which is
Ipsen
Medical effects of neuroendocrine tumors releasing substances into the blood
symptomatic control of the symptoms with somatostatin analogues octreotide or lanreotide. These analogues can help control the growth of the tumor itself and the
Carcinoid_syndrome
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
CJC-1295
Experimental drug
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Ibutamoren
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Adenosine
Class of drugs
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Growth_hormone_secretagogue
Peptide hormone produced by cows' pituitary glands
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Bovine_somatotropin
Type of hormone therapy
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Growth_hormone_therapy
Peptide selective agonist of the ghrelin/growth hormone secretagogue receptor
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Ipamorelin
Polypeptide placental hormone in humans
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Human_placental_lactogen
Medication used to manage and reduce diarrhea
Alosetron α₂-Adrenergic agonist Clonidine Somatostatin and analogs Octreotide Lanreotide Pasireotide Calcium channel blocker Nifedipine Pro-absorptive Agents Glucose
Antidiarrheal
Pharmaceutical drug
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Tesamorelin
Medical condition
secretion: diazoxide, somatostatin analogues including octreotide and lanreotide Medications that oppose the effects of insulin: glucagon Surgery to remove
Congenital_hyperinsulinism
Peptide hormone involved in appetite regulation
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Ghrelin
Causes of low blood sugar in humans
Jamaican vomiting sickness Ketotic hypoglycemia of infancy Kidney Failure Lanreotide Laron dwarfism Leucine-induced hypoglycaemia Levomepromazine Liver cancer
List of causes of hypoglycemia
List_of_causes_of_hypoglycemia
Amino acid-like chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Modified_GRF_(1-29)
Protein involved in the binding of the growth hormone
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Growth_hormone_receptor
Pharmaceutical drug
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Sermorelin
Class of compounds designed to mimic features of peptides
Atazanavir (Reyataz), Saquinavir (Invirase), Octreotide (Sandostatin), Lanreotide (Somatuline), Plecanatide (Trulance), Ximelagatran (Exanta), Etelcalcetide
Peptidomimetic
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
GHRP-6
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Examorelin
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Pralmorelin
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Anamorelin
Mammalian protein found in Homo sapiens
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Growth hormone–releasing hormone
Growth_hormone–releasing_hormone
Protein fragment in Homo sapiens
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Growth hormone-binding protein
Growth_hormone-binding_protein
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Capromorelin
Pharmaceutical drug
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Pegvisomant
Pharmaceutical drug
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Somatrem
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Octreotate
Protein-coding gene in the species Homo sapiens
somatostatin receptors are also found. Somatostatin analogs (i.e. Octreotide, Lanreotide ) are used to stimulate these receptors, and thus to inhibit further tumor
Somatostatin_receptor_2
Pharmaceutical drug
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Pasireotide
Type of radiotherapy
which somatostatin receptor is most strongly targeted. For example, DOTA-lanreotide (DOTALAN) has a lower affinity for receptor 2 and a higher affinity for
Peptide receptor radionuclide therapy
Peptide_receptor_radionuclide_therapy
Hormone that regulates growth and development
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Growth_hormone_1
Radioactive biochemical substance used for diagnosis or for study of receptor systems
progression despite receiving somatostatin analog therapy (octreotide or lanreotide), have a locally advanced, inoperable, or metastatic well-differentiated
Radioligand
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Tabimorelin
lanoteplase (INN) Lanoxicaps Lanoxin lanperisone (INN) lanproston (INN) lanreotide (INN) lansoprazole (INN) Lantidra Lantrisul Lantus (Sanofi-Aventis) lapaquistat
List_of_drugs:_La
Hormone pathway
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Hypothalamic–pituitary–somatotropic axis
Hypothalamic–pituitary–somatotropic_axis
Pharmaceutical drug classification
Triptorelin QH01CA98 Alarelin H01CB01 Somatostatin H01CB02 Octreotide H01CB03 Lanreotide H01CB04 Vapreotide H01CB05 Pasireotide H01CB06 Paltusotine H01CC01 Ganirelix
ATC_code_H01
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Somatorelin
Variant of somatotropin produced by placenta
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Growth_hormone_2
Pharmaceutical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Lonapegsomatropin
reiniose H 162478-58-3 C54H68N8O13 WS 9326A 125774-71-2 C54H69N11O10S2 lanreotide 108736-35-2 C54H70O6N4Mg chlorophyll d 519-63-1 C54H72N8O12 microcystin-LW
List of compounds with carbon numbers 50+
List_of_compounds_with_carbon_numbers_50+
Protein-coding gene in the species Homo sapiens
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Growth hormone secretagogue receptor
Growth_hormone_secretagogue_receptor
Receptor protein that binds with somatcrinin
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Growth-hormone-releasing hormone receptor
Growth-hormone-releasing_hormone_receptor
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Macimorelin
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Edotreotide
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
SM-130686
Protein-coding gene in the species Homo sapiens
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Somatostatin_receptor_4
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Relamorelin
Pharmaceutical drug
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Vapreotide
Cell surface protein binding somatostatin and triggering intracellular changes
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Somatostatin_receptor
Chemical compound
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Ulimorelin
Protein-coding gene in the species Homo sapiens
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Somatostatin_receptor_3
Protein-coding gene in the species Homo sapiens
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Somatostatin_receptor_1
Protein-coding gene in the species Homo sapiens
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Somatostatin_receptor_5
Cell surface receptors that bind somatomedins
Cortistatin-14 Depreotide Edotreotide Ilatreotide L-803,087 L-817,818 Lanreotide NNC 26-9100 Octreotate Octreotide Pasireotide Pentetreotide RC-160 Seglitide
Somatomedin_receptor
LANREOTIDE
LANREOTIDE
LANREOTIDE
LANREOTIDE
Surname or Lastname
English
English : variant of Morris 1.
Surname or Lastname
English and French
English and French : from a pet form of Gosse.A bearer of the name Gossett from Normandy, France, was established in Quebec city by 1677.
Boy/Male
Gujarati, Hindu, Indian, Malayalam, Marathi
Possessed of Good Qualities
Boy/Male
Australian, Danish, Norse
Son of Odd
Boy/Male
Muslim
Various, Soldier
Boy/Male
Indian, Sanskrit
Abundant; Full
Girl/Female
Hindu, Indian, Malayalam, Marathi
Lustrous
Girl/Female
Tamil
Sulojana | ஸà¯à®²à¯‹à®œà®¨à®¾
Somebody with beautiful eyes
Boy/Male
Hindu, Indian, Malayalam, Marathi
An Ancient Saint
Male
Irish
Modern form of Old Irish Gaelic Patraicc, PÃDRAIG means "patrician; of noble descent."
LANREOTIDE
LANREOTIDE
LANREOTIDE
LANREOTIDE
LANREOTIDE